Cannabics Pharmaceuticals Inc. announced that it has filed an additional four provisional patent applications with the Israel Patent Office, for cannabinoid-based drugs and treatments, designed for conditions associated with non-epileptic seizures and tremors. The patent protection of new disease specific and patient specific cannabinoid compositions and treatment protocols has already begun, with these four patent applications filed this month alone, with several and more in progress.